Results 81 to 90 of about 2,801 (152)

Efficacy and safety of PCSK-9 inhibitors in patients with acute coronary syndrome: a systematic review and network meta-analysis. [PDF]

BMC Cardiovasc Disord
Kao G, Chen C, Zhang Y, Xu Y, Xu G.
europepmc   +1 more source

Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice. [PDF]

Indian Heart J
Bansal M, Kasliwal RR, Chandra P, Kapoor R, Chouhan N, Bhan A, Trehan N.   +6 more
europepmc   +1 more source

Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems. [PDF]

J Manag Care Spec Pharm
McCormick D, Taub PR, Carter J, Moreo K, Heggen CL.   +4 more
europepmc   +1 more source

Efficacy and safety of low-dose rosuvastatin/ezetimibe for dyslipidemia in patients with rheumatoid arthritis or osteoarthritis. [PDF]

Medicine (Baltimore)
Bak SH, Lee KA, Kim SS, Kim SH, Hong SJ, Hong SJ, Kim HS.   +6 more
europepmc   +1 more source

Naturally Occurring PCSK9 Inhibitors: An Updated Review. [PDF]

Molecules
Huh J, Kim H.
europepmc   +1 more source

PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTs. [PDF]

Open Heart
Ho VQT, Tran NB, Nguyen N, Arrighini GS, Downes D, Dandamudi M, Ferrara VZ, Ho THQ, Walia H, Barbagelata A, Leucker TM, Giorgi J.   +11 more
europepmc   +1 more source

Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe. [PDF]

Drug Des Devel Ther
An H, Shin D.
europepmc   +1 more source

Lipid-lowering effect of combined therapy with high-intensity statins and CETP inhibitors: a Systematic Review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Xiang L, Wu H, Zhao Z, Wu T, Lv D, Wu P, Zheng Y, Huang Q, Xu T.   +8 more
europepmc   +1 more source

Lipid-lowering therapies for aortic stenosis: a drug-target Mendelian randomization study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Ciofani JL, Han D, Rao K, Gill D, Woolf B, Rahimi K, Allahwala UK, Bhindi R.   +7 more
europepmc   +1 more source

Effects of the 2019 guideline update on lipid-lowering therapy in patients with acute coronary syndromes. [PDF]

Clin Res Cardiol
Galli L, Bernhard J, Schrutka L, Haider P, Distelmaier K, Hengstenberg C, Krychtiuk KA, Speidl WS.   +7 more
europepmc   +1 more source